You can buy or sell INFI and other stocks, options, ETFs, and crypto commission-free!
Infinity Pharmaceuticals, Inc. operates as a biopharmaceutical company, which engages in discovering, developing and delivering medicines for people with cancer. It focuses on drug development. Read More The company was founded by Steven H. Holtzman on March 22, 1995 and is headquartered in Cambridge, MA.
52 Week High
52 Week Low
Yahoo FinanceMay 10
Edited Transcript of INFI earnings conference call or presentation 7-May-19 8:30pm GMT
Q1 2019 Infinity Pharmaceuticals Inc Earnings Call Cambridge May 10, 2019 (Thomson StreetEvents) -- Edited Transcript of Infinity Pharmaceuticals Inc earnings conference call or presentation Tuesday, May 7, 2019 at 8:30:00pm GMT TEXT version of Transcript ================================================================================ Corporate Participants ================================================================================ * Adelene Q. Perkins Infinity Pharmaceuticals, Inc. - Chairman &...
Infinity (INFI) Earnings and Sales Miss Estimates in Q1
Infinity Pharmaceuticals Inc. INFI reported a loss of 24 cents in the first quarter of 2019, wider than a loss of 18 cents in the year-ago quarter. Loss was also wider than the Zacks Consensus Estimate of a loss of 5 cents. Revenues in the first quarter were $2.1 million, which mainly relates to the achievement of a $2-million milestone from PellePharm for the initiation of a phase III study, investigating patidegib (a hedgehog pathway inhibitor) in patients with Gorlin Syndrome. The company did not realiz...
Expected Aug 6, After Hours